Guangxi Wuzhou Zhongheng Group Acquires Innovative Heart Failure Drug Project, Boosts Pharmaceutical Strategy
Guangxi Wuzhou Zhongheng Group Co Ltd has made a significant move in the pharmaceutical sector by acquiring an innovative heart failure drug project, positioning the company to capitalize on the growing demand for advanced treatments in China.
- Guangxi Wuzhou Zhongheng Group Co Ltd
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
3 minutes to read